Family CaregiversFCA 4 FC-EAMANCT07681401
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood
A study testing Financial Counseling and Advocacy in people with Family Caregivers and Dementia, run by University of Utah at 1 site in United States.
Trial summary
The goal of this National Institutes of Health (NIH) Stage 1a study is to develop and pilot test a research- and community-informed financial counseling and advocacy (FCA) intervention for dementia family caregivers in early and middle adulthood. Read more about this study
- Who is it for?
- Ages 25 to 55 yearsHealthy volunteers can take part
- Conditions the study is for
- Family Caregivers, Dementia, Financial Wellbeing
- What is being tested?
- Financial Counseling and Advocacy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Apr 2026to Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 55 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Caring for a family member, neighbor, or friend with ADRD
- Providing care for 20 or more hours per week,
- Technology access for Zoom visits
- English speaking
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Utah College of Nursing
Salt Lake City, Utah, 84112
Megan Thomas Hebdon, (801) 581-3414, meg.hebdon@utah.edu
Megan Thomas Hebdon, PhD, DNP
About this study
Official title: Financial Counseling and Advocacy for Alzheimer's Disease and Related Dementias Family Caregivers in Early and Middle Adulthood
The goal of this National Institutes of Health (NIH) Stage 1a study is to develop and pilot test a research- and community-informed financial counseling and advocacy (FCA) intervention for dementia family caregivers in early and middle adulthood. The main question it aims to answer is:
Is a research- and community-informed financial counseling and advocacy intervention usable, feasible and acceptable for dementia family caregivers in early and middle adulthood?
Participants will engage in a four-week single group financial counseling and advocacy intervention and complete pre- and post-intervention measures addressing financial well-being, caregiver strain, workplace productivity, and flourishing along with usability, acceptability, and feasibility measures.
- Conditions
- Family Caregivers, Dementia, Financial Wellbeing, Financial Coaching
- Being tested
- Financial Counseling and Advocacy
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Financial Counseling and AdvocacyBehavioural
Financial assessment, coaching, self-advocacy support, referrals, educational toolkit, and follow-up
| Study group | Role | What they receive |
|---|---|---|
| Financial Counseling and Advocacy Arm | Experimental | Not described Receives: Behavioral: Financial Counseling and Advocacy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of Intervention Measure (FIM)
Higher score indicates greater feasibility (Range 4-20)
Measured: After intervention completion at 4 weeks
Acceptability of Intervention Measure (AIM)
Higher score indicates greater acceptability (Range 4-20)
Measured: After intervention completion at 4 weeks
Study Usability
Higher score indicates greater usability (Range: 5-25)
Measured: After intervention completion at 4 weeks
Secondary outcomes (4)
Modified Caregiver Strain Index
Higher score indicates higher caregiver strain (Range: 0-26)
Measured: At baseline and after intervention completion at 4 weeks
Workplace Productivity and Activity Impairment
Higher score indicates greater presenteeism, absenteeism, work productivity loss, and activity impairment (Range: 0-100)
Measured: At baseline and after intervention completion at 4 weeks
Consumer Financial Protection Bureau Financial Well-Being Scale
Higher score indicates greater financial well-being (Range: 0-40)
Measured: At baseline and after intervention completion at 4 weeks
Harvard Flourishing Measure
Higher score indicates greater flourishing in the following domains: Happiness and Life Satisfaction, Mental and Physical Health, Meaning and Purpose, Character and Virtue, and Close Social Relationships, and Financial and Material Stability (Range: 0-10 for each subscale and overall scale score)
Measured: At baseline and after intervention completion at 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2026
- Study start10 Apr 2026
- Primary completionOct 2026 (estimated)
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Family CaregiversStudies of the same condition, open and under way.
- More trials run by University of UtahThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Megan Thomas Hebdon, University of Utah
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07681401
- Sponsor's protocol ID
- IRB_00185128
- Acronym
- FCA 4 FC-EAMA
- Status last verified
- Jun 2026
- First submitted
- 5 May 2026
- Last updated
- 2 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD sharing was not part of the IRB protocol. This is a small scale pilot study, and procedures and findings will be reported in full.
Study at a glance
From the registry record, last updated by the sponsor on 2 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Financial Counseling and Advocacy for Alzheimer's Disease and Related Dementias Family Caregivers in Early and Middle Adulthood
- ClinicalTrials.gov ID
- NCT07681401
- Acronym / sponsor ID
- FCA 4 FC-EAMA / IRB_00185128
- Conditions
- Family Caregivers, Dementia, Financial Wellbeing, Financial Coaching
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- University of UtahUniversity, hospital or other
- Study start
- 10 Apr 2026 (actual)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Oct 2026 (estimated)
- First posted
- 2 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this National Institutes of Health (NIH) Stage 1a study is to develop and pilot test a research- and community-informed financial counseling and advocacy (FCA) intervention for dementia family caregivers in early and middle adulthood. The main question it aims to answer is:
Is a research- and community-informed financial counseling and advocacy intervention usable, feasible and acceptable for dementia family caregivers in early and middle adulthood?
Participants will engage in a four-week single group financial counseling and advocacy intervention and complete pre- and post-intervention measures addressing financial well-being, caregiver strain, workplace productivity, and flourishing along with usability, acceptability, and feasibility measures.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Financial Counseling and Advocacy Arm | Experimental | Behavioral: Financial Counseling and Advocacy |
Who may qualify
- Ages
- 25 to 55 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Caring for a family member, neighbor, or friend with ADRD
- Providing care for 20 or more hours per week,
- Technology access for Zoom visits
- English speaking
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Financial Counseling and AdvocacyFinancial assessment, coaching, self-advocacy support, referrals, educational toolkit, and follow-up | Behavioural | Financial Counseling and Advocacy Arm |
Primary outcome
Feasibility of Intervention Measure (FIM)
Time frame: After intervention completion at 4 weeks
Higher score indicates greater feasibility (Range 4-20)
Acceptability of Intervention Measure (AIM)
Time frame: After intervention completion at 4 weeks
Higher score indicates greater acceptability (Range 4-20)
Study Usability
Time frame: After intervention completion at 4 weeks
Higher score indicates greater usability (Range: 5-25)
4 secondary outcomes
Modified Caregiver Strain Index
Time frame: At baseline and after intervention completion at 4 weeks
Workplace Productivity and Activity Impairment
Time frame: At baseline and after intervention completion at 4 weeks
Consumer Financial Protection Bureau Financial Well-Being Scale
Time frame: At baseline and after intervention completion at 4 weeks
Harvard Flourishing Measure
Time frame: At baseline and after intervention completion at 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jul 2026.
- Individual participant dataSharing planned: No. IPD sharing was not part of the IRB protocol. This is a small scale pilot study, and procedures and findings will be reported in full.
Related trials for Family Caregivers
Not yet recruiting
ICU-SUCCEED for Survivors of Acute Respiratory Failure and Their Caregivers
Acute Respiratory Failure, Critical Illness
Enrolling by invitation
BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)
Traumatic Brain Injury
Not yet recruiting
Parenting Program for Young Children With Spina Bifida
Spina Bifida
Recruiting
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia
Lewy Bodies Disease, Depression Disorder
Recruiting
Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale
Caregiver Anxiety, Acquired Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Financial Counseling and Advocacy in people with Family Caregivers and Dementia, run by University of Utah at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Megan Thomas Hebdon ((801) 581-3414, meg.hebdon@utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of Intervention Measure (FIM) (time frame: After intervention completion at 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.